Published in Head Neck on October 01, 1997
Adjuvant immunotherapy for patients with melanoma. Head Neck (1998) 0.75
The role of cholecystectomy in acquired immunodeficiency syndrome. J Am Coll Surg (1997) 2.57
Massive localized lymphedema of the thigh in a morbidly obese patient. Eur J Surg Oncol (2009) 1.41
Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med (1989) 1.23
Recurrent malignant chondroid syringoma of the foot: a case report and review of the literature. Am J Clin Oncol (2000) 1.21
Ectopic supernumerary kidney, a cause of para-aortic mass: case report and review. Am Surg (2001) 1.19
Gestational carcinoma of the female breast. Curr Probl Cancer (1983) 1.17
Cholecystectomy in the elderly. Am J Surg (1988) 1.13
Pyogenic liver abscess secondary to asymptomatic sigmoid diverticulitis. Ann Surg (1976) 1.08
Inflammatory oncotaxis after testing the skin of the cancer patient. Cancer (1981) 1.00
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg (1998) 1.00
Long-term survival after locally aggressive anorectal melanoma. Am Surg (1998) 0.95
Appendicitis in patients with acquired immunodeficiency syndrome. J Am Coll Surg (1997) 0.93
Negative appendicectomy rate as a quality metric in the management of appendicitis: impact of computed tomography, Alvarado score and the definition of negative appendicectomy. Ann R Coll Surg Engl (2012) 0.91
Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response. J Immunol (1990) 0.88
Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines. Cancer Res (1981) 0.88
A new approach in specific, active immunotherapy. Cancer (1977) 0.86
A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates. Cancer (1986) 0.85
Carcinoma of the breast during pregnancy: a review and update on treatment options. Surg Oncol (1999) 0.85
Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice. Cancer Immunol Immunother (1998) 0.85
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). Am Surg (1986) 0.84
Coronary artery bypass grafting in patients with human immunodeficiency virus. J Card Surg (1997) 0.83
Cholecystectomy in the elderly. Am Surg (1988) 0.82
Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model. Cancer Immunol Immunother (1990) 0.82
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. Cancer (1995) 0.82
Crohn's disease of the appendix. Surgery (1990) 0.81
A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatment. J Biol Response Mod (1983) 0.81
Gastric cancer in the elderly. Am Surg (1987) 0.81
Effect of splenectomy on the growth of murine colon tumors. J Surg Oncol (1983) 0.80
Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial. Ann Surg (1997) 0.79
Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma. J Immunother Emphasis Tumor Immunol (1994) 0.79
Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case. Dis Colon Rectum (2001) 0.79
Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials. Surg Oncol (2001) 0.79
Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial. Ann Surg Oncol (1996) 0.78
Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model. Cancer Immunol Immunother (1994) 0.78
T-cell clones that react against autologous human tumors. Immunol Rev (1990) 0.78
Bilateral adrenalectomy in treatment of disseminated breast cancer. Am J Surg (1976) 0.78
The surgeon's database for AIDS: a collective review. J Am Coll Surg (1997) 0.77
The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma. Am Surg (1990) 0.77
Opposite effects of lithium on proximal and distal caspases of immature and mature primary neurons correlate with earlier paradoxical actions on viability. Neurochem Res (2001) 0.77
Vaccinia virus-infected C-C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic Balb/c mice from tumor cell challenge. J Surg Oncol (1989) 0.76
Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma. G Ital Dermatol Venereol (2008) 0.76
Balloon blunt-tip trocar for laparoscopic cholecystectomy: improvement over the traditional Hasson and Veress needle methods. J Laparoendosc Adv Surg Tech A (2001) 0.76
Use of epidural anesthesia and spontaneous ventilation during transabdominal colon and rectal procedures in selected high-risk patient groups. Dis Colon Rectum (1997) 0.75
Vaccinia virus oncolysates in the treatment of malignant melanoma. Cancer Treat Res (1988) 0.75
Cholecystectomy and AIDS. J Am Coll Surg (1997) 0.75
Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies. J Biol Response Mod (1989) 0.75
Tumor imaging of Dalton's lymphoma using antibody-desferal-Ga-67 complex. Int J Radiat Oncol Biol Phys (1989) 0.75
Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysates. Surgery (1984) 0.75
Specific tumor immunity produced by the injection of vaccinia viral oncolysates. J Surg Res (1982) 0.75
Palliative treatment of recurrent obstructing gastric cancer. A case report of successful treatment with three self-expanding metallic stents. Surg Endosc (2000) 0.75
[The treatment of advanced malignant melanoma with vaccina oncolysates (author's transl)]. Nouv Presse Med (1979) 0.75
Cancer to the inguinal nodes from an unknown primary site. J Surg Oncol (1981) 0.75
Survival after malignant melanoma in a black child. A case report and review of the literature. Am J Clin Oncol (1984) 0.75
Prospects for gene therapy and lymphokine therapy for metastatic melanoma. Ann Plast Surg (1992) 0.75
Tumor targeting potential of liposomes encapsulating Ga-67 and antibody to Dalton's lymphoma associated antigen (anti-DLAA). Int J Radiat Oncol Biol Phys (1987) 0.75
Ligation device assisting low anterior anastomosis. Dis Colon Rectum (1995) 0.75
Management of the pregnant patient with carcinoma of the breast. Surg Gynecol Obstet (1990) 0.75
Combinatorial antibodies against human malignant melanoma. Hybridoma (1997) 0.75
Cancer of the colon and rectum. A review. Postgrad Med (1975) 0.75
Thoracoscopy in acquired immunodeficiency syndrome. J Thorac Cardiovasc Surg (1997) 0.75
Acute iron intoxication in an adult. JAMA (1974) 0.75
Coronary pseudoaneurysm after angioplasty. Am Surg (1995) 0.75
Active specific adjuvant immunotherapy with vaccinia melanoma oncolysate. Ann Plast Surg (1992) 0.75
The treatment of cancer of the large intestine. Surg Gynecol Obstet (1976) 0.75
Avoidance of anastomotic complications in low anterior resection of the rectum. Dis Colon Rectum (1997) 0.75
Primary gastrointestinal non-Hodgkin's lymphoma: increasingly AIDS-related. Am Surg (1998) 0.75
A new approach in the immunotherapy of carcinoma of the colon and rectum. J Surg Oncol (1980) 0.75
Perfusion therapy for extremity melanoma. Arch Surg (1976) 0.75
Clinical trials with VMO for melanoma. Ann N Y Acad Sci (1993) 0.75
Surgical management of melanoma. Surg Oncol (1995) 0.75
Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2. J Surg Res (1988) 0.75
Vaccinia colon oncolysate immunotherapy for murine hepatic metastases can be modulated with low-dose interleukin-2. Third place winner: Conrad Jobst Award. Am Surg (1988) 0.75
Serum fucose as a monitor for recurrent malignancy. J Surg Oncol (1978) 0.75
Transplantation immunity and cross-protection of two cultured murine colon lines. J Natl Cancer Inst (1983) 0.75
A new approach in immunotherapy with Vaccinia oncolysates. Surg Forum (1977) 0.75
Bedside percutaneous tracheostomy in acquired immunodeficiency syndrome. Am Surg (1998) 0.75
Pacemaker leads: a simple atraumatic method for replacing pacemaker electrodes. Ann Thorac Surg (2000) 0.75
Gastric epithelioid leiomyoma causing intraperitoneal hemorrhage. South Med J (1986) 0.75
Characterization of in vivo cross-reactive tumor resistance between two cultured murine colon lines. J Surg Res (1983) 0.75
Resection of metastatic colorectal cancer to the liver. Surgery (1981) 0.75
The role of tracheostomy in acquired immunodeficiency syndrome. Ann Thorac Surg (1997) 0.75
Regarding: Self-expanding knitted polypropylene mesh facilitates laparoscopic inguinal herniorrhaphy. J Laparoendosc Adv Surg Tech A (1999) 0.75
Active specific immunotherapy with vaccinia melanoma oncolysate. Mt Sinai J Med (1992) 0.75
Neuraminidase immunotherapy: serum potentiation of lymphocyte cytotoxicity related to immunoglobulin levels. J Surg Oncol (1976) 0.75
Immunotherapy in colorectal cancer. Mo Med (1981) 0.75